Welcome to CDC stacks | CDC--detect and protect against antibiotic resistance : FY 2015 President’s budget request : $30 million - 27768 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
CDC--detect and protect against antibiotic resistance : FY 2015 President’s budget request : $30 million
  • Published Date:
    3/4/14
  • Language:
    English
Filetype[PDF-390.03 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    Antibiotic Resistance is a rapidly growing threat to our nation and the world. Some antibiotic resistant infections are already untreatable. As AR grows, the antibiotics used to treat infections do not work as well or at all. The loss of effective antibiotic treatments can cripple the ability to fight routine infectious complications of asthma and arthritis. It will also undermine treatment of infectious complications in patients with other diseases such as diabetes and cancer. Each year in the United States it’s estimated that over 2 million illnesses and about 23,000 deaths are caused by AR. Without CDC’s dedicated work to stop AR now, minor infections can become life threatening and put at risk the ability to perform routine surgeries and treat diseases.

    A total of $30 million is requested for FY 2015 in CDC’s Budget Authority for the Detect and Protect Against AR Initiative.

    Priority Areas for AR Investments:

    • Support a “Detect” network of five regional labs that will characterize emerging resistance and rapidly identify outbreaks of dangerous AR threats

    • Scale up healthcare prevention collaboratives focused on improving antibiotic use and preventing deadly infections caused by Clostridium difficile (C. diff ), carbapenem- resistant enterobacteriaceae (CRE), Pseudomonas, and methicillin- resistant Staphylococcus aureus (MRSA)

    • Improve outpatient antibiotic prescribing and target community AR threats inlcuding resistant Salmonella, and drug-resistant gonorrhea

    • Establish lab library of resistant isolates to help support drug and diagnostic development

    CS244890S

  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: